Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

M. Joerger, J. A. Burgers, P. Baas, V. D. Doodeman, P. H. M. Smits, R. S. Jansen, L. D. Vainchtein, H. Rosing, A. D. R. Huitema, J. H. Beijnen, J. H. M. Schellens
  • Cancer Chemotherapy and Pharmacology, May 2011, Springer Science + Business Media
  • DOI: 10.1007/s00280-011-1670-4
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Robert Jansen